Answers are grounded in this paper and cite their sources.
Aim: Chronic hepatitis B (CHB) remains a major global cause of hepatocellular carcinoma (HCC), particularly in regions with high hepatitis B virus endemicity. Meanwhile, metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a rapidly growing metabolic contributor to hepatocarcinogenesis. Their co-occurrence influences liver cancer development through complex biological interactions. This review aims to summarize recent advances regarding how CHB-MAFLD comorbidity affects HCC risk and the development of related predictive models. Methods: This review synthesizes evidence from recent clinical and basic research exploring the relationship between CHB-MAFLD comorbidity and cancer risk. It evaluates the performance of traditional and next-generation risk prediction models and examines the potential of artificial intelligence in integrating multimodal data to improve accuracy. Results: The underlying pathophysiology exhibits a dual nature. While metabolic disturbances can suppress hepatitis B virus replication and facilitate surface antigen clearance, metabolic dysfunctions such as obesity and diabetes independently accelerate fibrosis and increase cancer risk. This paradox originates from heterogeneous effects: simple steatosis may reduce risk, whereas cumulative metabolic abnormalities increase risk in a dose-dependent manner. Although traditional models retain prognostic value, their sensitivity is suboptimal. Next-generation models incorporating metabolic parameters have demonstrated improved accuracy. Furthermore, machine learning shows considerable potential for modeling complex non-linear interactions and enabling individualized risk prediction. Conclusion: This review summarizes how metabolic dysfunction-associated fatty liver disease influences cancer risk in patients with chronic hepatitis B. It provides a framework for identifying high-risk individuals to guide stratified, precision management strategies.
No takes yet. Share an insight, caveat, or question.
Tao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: